Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Allena Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −2 vs. Q4 2021
- Shares held
- 8.05M
- −8.96M (−52.7%) vs. Q4 2021
- Total value
- $1.86M
- −$8.21M (−81.5%) vs. Q4 2021
- New holders
- 4
- 6 more added
- Sold out
- 6
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 2 | $4.00K |
| Q2 2022 | 25 | $1.71M |
| Q1 2022 | 28 | $1.86M |
| Q4 2021 | 30 | $10.1M |
| Q3 2021 | 36 | $18.0M |
| Q2 2021 | 29 | $28.1M |
| Q1 2021 | 30 | $28.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Allena Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $645.0K | 6.58% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,581,193 | $597.0K | 0.00% | −709,562−21.6% | Reduced |
| Frazier Management LLC | 1,019,288 | $236.0K | 11.87% | −632,069−38.3% | Reduced |
| Geode Capital Management, LLC | 335,573 | $77.0K | 0.00% | +4,974+1.5% | Added |
| BlackRock Inc. | 258,920 | $61.0K | 0.00% | −5,319−2.0% | Reduced |
| State Street Corp | 205,058 | $47.0K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 173,162 | $40.0K | 0.00% | +11,662+7.2% | Added |
| Bridgeway Capital Management, LLC | 124,200 | $29.0K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 106,183 | $25.0K | 0.00% | −1,138,826−91.5% | Reduced |
| Northern Trust Corp | 89,363 | $21.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 58,401 | $14.0K | 0.00% | +43,532+292.8% | Added |
| Virtu Financial LLC | 43,414 | $10.0K | 0.00% | −90,415−67.6% | Reduced |
| Level Four Advisory Services, LLC | 40,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,613 | $9.00K | 0.00% | +7,788+26.1% | Added |
| LPL Financial LLC | 30,550 | $7.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 33,000 | $7.00K | 0.00% | +10,000+43.5% | Added |
| Golden Green, Inc. | 25,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13,934 | $4.00K | 0.00% | −46,065−76.8% | Reduced |
| Morgan Stanley | 11,545 | $3.00K | 0.00% | −1,033,936−98.9% | Reduced |
| Jane Street Group, LLC | 12,558 | $3.00K | 0.00% | −688−5.2% | Reduced |
| RFG Advisory, LLC | 11,000 | $3.00K | 0.00% | +11,000 | New |
| Spire Wealth Management | 10,000 | $2.00K | 0.00% | −81,940−89.1% | Reduced |
| Victory Capital Management Inc | 10,745 | $2.00K | 0.00% | −306−2.8% | Reduced |
| Tower Research Capital LLC (TRC) | 10,645 | $2.00K | 0.00% | +10,645 | New |
| Bank of America Corp | 5,800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,968 | $1.00K | 0.00% | +16+0.5% | Added |
| Citigroup Inc | 2,600 | $1.00K | 0.00% | +2,600 | New |
| Prospera Financial Services Inc | 5,550 | $1.00K | 0.00% | +5,550 | New |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −4,000,000−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −980,200−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −284,285−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| TAP Consulting, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |